一品红子公司获左氧氟沙星口服溶液注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug registration certificate of levofloxacin oral solution, indicating a significant advancement in its product portfolio [1] Group 1: Company Developments - The company's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has been granted the drug registration certificate for levofloxacin oral solution [1] - Levofloxacin is classified as a third-generation fluoroquinolone antibiotic, which works by inhibiting bacterial DNA gyrase activity, thereby obstructing bacterial DNA replication [1] Group 2: Product Characteristics - Levofloxacin exhibits a broad antibacterial spectrum and strong antibacterial action, making it a valuable addition to the company's offerings [1]